A prospective randomized trial to compare recombinant follicle stimulating hormone (rFSH) versus highly purified human menotropin (HP-hMG) for controlled ovarian stimulation on blastocyst aneuploidy rates

Journal article

Open access

Peer reviewed

S. Anderson, H. Norris, T. Hartlein, E.B. Davies, D. Brasile, B. Gocial, J.J. Orris and M.J. Glassner

Fertility and sterility, v 110(4), pp e201-e201

Sep 2018

Files and links (1)

url

https://doi.org/10.1016/j.fertnstert.2018.07.584View

Published, Version of Record (VoR)Open Access (Publisher-Specific), Open

10 Record Views

Title: A prospective randomized trial to compare recombinant follicle stimulating hormone (rFSH) versus highly purified human menotropin (HP-hMG) for controlled ovarian stimulation on blastocyst aneuploidy rates
Creators: S. Anderson - Drexel University
H. Norris - Drexel University
T. Hartlein - Main Line Fertility
E.B. Davies - Main Line Fertility
D. Brasile - Main Line Fertility
B. Gocial - Drexel University
J.J. Orris - Main Line Fertility
M.J. Glassner - Main Line Fertility
Publication Details: Fertility and sterility, v 110(4), pp e201-e201
Publisher: Elsevier
Resource Type: Journal article
Language: English
Academic Unit: Obstetrics and Gynecology
Web of Science ID: WOS:000448713600499
Other Identifier: 991019169665804721

Data related to this publication, from InCites Benchmarking & Analytics tool:

Web of Science research areas: Obstetrics & Gynecology; Reproductive Biology